Mark Goldin
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Venous Thromboembolism Diagnosis and Management 20
-
- COVID-19 Clinical Research Studies 11
- HIV/AIDS Research and Interventions 2
- Co-authors
- Alex C. Spyropoulos (17 shared papers)Dimitrios Giannis (8 shared papers)Thomas McGinn (6 shared papers)Stuart L. Cohen (5 shared papers)Saurav Chatterjee (4 shared papers)Jamie S. Hirsch (4 shared papers)Eugenia Gianos (4 shared papers)Kevin Coppa (4 shared papers)
- Journals
- Thrombosis and Haemostasis (3 papers)American Journal of Therapeutics (3 papers)Journal of Thrombosis and Thrombolysis (3 papers)Journal of Thrombosis and Haemostasis (3 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- United StatesCanadaRussia
In The Last Decade
Mark Goldin
27 papers receiving 346 citations
Peers
Comparison fields: 5 of 53
- Internal Medicine 166
- Virology 72
- Infectious Diseases 198
- Neurology 71
- Oncology 84
Countries citing papers authored by Mark Goldin
This map shows the geographic impact of Mark Goldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Goldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Goldin more than expected).
Fields of papers citing papers by Mark Goldin
This network shows the impact of papers produced by Mark Goldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Goldin. The network helps show where Mark Goldin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Goldin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 44 | |
| 2 | 2021 | 41 | |
| 3 | 2010 | 32 | |
| 4 | 2021 | 30 | |
| 5 | 2021 | 27 | |
| 6 | 2021 | 25 | |
| 7 | 2022 | 24 | |
| 8 | 2016 | 22 | |
| 9 | 2023 | 15 | |
| 10 | 2011 | 15 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2021 | 5 | |
| 16 | 2018 | 4 | |
| 17 | 2024 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2021 | 2 |
About Mark Goldin
Mark Goldin is a scholar working on Internal Medicine, Infectious Diseases, Cardiology and Cardiovascular Medicine, Oncology and Surgery, having authored 29 papers that have together received 349 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (20 papers), COVID-19 Clinical Research Studies (11 papers), COVID-19 and healthcare impacts (8 papers), Atrial Fibrillation Management and Outcomes (5 papers), Long-Term Effects of COVID-19 (4 papers), Acute Myocardial Infarction Research (3 papers), HIV Research and Treatment (2 papers) and HIV/AIDS Research and Interventions (2 papers). The work is most often cited by research in Internal Medicine (166 citations), Virology (72 citations), Infectious Diseases (198 citations), Neurology (71 citations) and Oncology (84 citations). Mark Goldin has collaborated with scholars based in United States, Canada and Russia. Frequent co-authors include Alex C. Spyropoulos, Dimitrios Giannis, Thomas McGinn, Stuart L. Cohen, Saurav Chatterjee, Jamie S. Hirsch, Eugenia Gianos, Kevin Coppa, Nina Kohn and Linqi Zhang. Their work appears in journals such as Thrombosis and Haemostasis, American Journal of Therapeutics, Journal of Thrombosis and Thrombolysis, Journal of Thrombosis and Haemostasis and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.